Form D · Other Investment Fund

Innovatus Life Sciences Offshore Fund I, LP

Grand Cayman, E9 · CIK 0001700517

Offering snapshot reported Mar 29, 2019 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$5M
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 29, 2019AmendmentYet to sellNo comparison0SEC filing
Mar 16, 2018AmendmentYet to sellNo comparison0SEC filing
Mar 17, 2017InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-282838
Clarification of Item 11 - The General Partner, in consultation with the Manager, may accept commitments of lesser amounts.

Source: Form D, filed Mar 29, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Andrew Dym Executive
Andrew Hobson Executive
N/A Innovatus Capital Partners, Llc Promoter
N/A Innovatus Flagship Offshore Parent Gp, Llc Executive
N/A Innovatus Flagship Parent Gp, Llc Executive
N/A Innovatus Life Sciences Offshore Gp, Lp Executive
David Schiff Executive
Joseph Schottland Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Mt. Ozannes Corp Svcs (Cayman) Ltd 94 Solaris Ave., Camana Bay, Po Box 1348
Grand Cayman, E9, KY1-1108